新闻
再创佳绩：学院获批研资局八项优配研究金
2026年7月3日
学院在研究资助局「优配研究金」2026/27 竞逐中再创佳绩，成功囊括八项研究拨款。获资助项目数量连续两年稳步攀升，充分彰显学院在中医药科研领域的卓越实力与领先地位。
本年度获资助的项目聚焦中医药、生物医学和创新药物研发等前沿领域，并贯彻跨学科研究的理念。相关研究深具转化潜力，有望拓展崭新治疗策略，阐明创新药物与疗法的机制，推动整合医学与疾病管理模式的发展。
院长李敏教授对学院科研人员的骄人成绩深感自豪，她表示：「学院近年在校外竞争性资助中屡获佳绩，新晋研究人员表现尤其瞩目，充分体现了学院的科研实力和人才培育成果广获学界肯定。」
展望未来，学院将继续立足科研创新前沿，致力融合传统中医药智慧与现代科学技术，为增进人类健康谋福祉作出更大贡献。
由学院领导的2026/27优配研究金资助项目（只提供英文版）
Principal Investigator | Project Title |
Professor Li Min 李敏教授 | Investigating the Specific Roles of TFE3 in CAPON-Mediated Tauopathy in Alzheimer's disease and Therapeutic Potential of Corynoxine |
Professor Zhang Ge 张戈教授 | Sclerostin-loop3-LRP4 interaction in adipocytes could be required by sclerostin to impair whole-body lipid/glucose metabolism |
Professor Han Quanbin Simon 韩全斌教授 | Investigating the Structure-Activity Relationships and Binding Interactions between polysaccharides and GP2/TLR4 receptors: Implications for Intestinal Lymphatic Absorption and Immune Modulation |
Professor Cheung King-ho 张敬浩教授 | Deciphering Genistein’s Neuroprotective |
Professor Li Fangfei 李芳菲教授 | Targeted Degradation of Nuclear uPA to Inhibit Perineural Invasion in Pancreatic Cancer via PROTAC Strategy |
Dr. Li Lifeng Cherry 李利锋博士 | From a traditional pediatric remedy Goat Bezoar to functional food: Urolithins as a novel intervention for pediatric respiratory health |
Dr. Chen Qilei 陈绮蕾博士 | Investigating a novel synovial crosstalk: Fibroblast-like synoviocyte exosomal miRNAs drive pathogenic macrophage reprogramming in rheumatoid arthritis |
Dr. Cheung Chat-pan Kenneth 张质彬博士 | Investigating Hyodeoxycholic Acid as a Regulator of Immunometabolism in Rheumatoid Arthritis |
